Innate Pharma (IPHA) Selling, General & Administrative (2019 - 2025)
Innate Pharma (IPHA) Selling, General & Administrative (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.13 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 216.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 593.21 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 347.92 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -196.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 247.47 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 161.89 Mn |
| 10 | Innate Pharma | 202.03 Mn | 202.03 Mn | - | -22.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.58 Mn |
| Jun 30, 2025 | -11.06 Mn |
| Dec 31, 2024 | -21.07 Mn |
| Jun 30, 2024 | -10.32 Mn |
| Dec 31, 2023 | -19.68 Mn |
| Jun 30, 2023 | -9.96 Mn |
| Dec 31, 2022 | -22.89 Mn |
| Jun 30, 2022 | -12.95 Mn |
| Dec 31, 2021 | -29.20 Mn |
| Jun 30, 2021 | -23.27 Mn |
| Dec 31, 2020 | -22.64 Mn |
| Jun 30, 2020 | -15.96 Mn |
| Dec 31, 2019 | -28.56 Mn |
| Jun 30, 2019 | -10.44 Mn |